Mylan - Knowledge

578:. The company had entered into an exclusive agreement with Profarmica, an Italian company that supplied drug ingredients, after which the company's competitors had higher prices and a diminished supply of raw ingredients for lorazepam and other drugs. Before the round of price increases the price of generic drugs had been 5 - 10% of the price of branded drugs and afterwards it was around 50%. The FTC filed suit at the end of 1998 and 32 states filed parallel actions. The case was settled in 2000, with the company paying a total of $ 147M -- $ 100M in disgorged profits into a fund to reimburse consumers and state agencies that had overpaid, $ 8 million in attorney's fees to the State Attorneys General, $ 35 million, plus $ 4 million in attorney's fees, to settle certain class actions with insurers and managed care organizations—and Mylan and three ingredient suppliers ( 1120:. The last price increase coincided with the company's airing of a new line of TV commercials that were described as "shocking" and "no holds barred", depicting an anaphylactic reaction from the point of view of the young woman having it at a party, and ending with the young woman seeing her swollen and hive-covered face in the mirror before she collapses. In response to criticism, the company increased financial assistance available for some patients to purchase EpiPens, a gesture that was called a "classic public relations move" by Harvard Medical School professor Aaron Kesselheim. The up to $ 300 saving cards can only be used by a small number of people who need the drug, and no one on 512:

compared with Dyazide's 25 mg hydrochlorothiazide and 50 mg triamterene). This drug had to get approval as a new drug, as opposed to a generic. Their product was called Maxzide and was approved in 1984. The higher dose allowed once per day dosing, which the company and its marketing partner, Lederle, believed would help it compete against Dyazide, which had $ 210M in sales in 1983. However, the company's patents on the drug were declared invalid in court, and its marketing exclusivity expired in 1987, prompting a rush of generic competition.

230: 4335: 40: 1998: 3153:"Mylan Expands Its Voluntary Nationwide Recall of Valsartan Tablets, USP, Amlodipine and Valsartan Tablets, USP, and Valsartan and Hydrochlorothiazide Tablets, USP, to all Lots Within Expiry Due to The Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Found in the Active Pharmaceutical Ingredient" 504:; it had been on the market since 1965 and its patents had expired in 1980. Complications arose with the introductions of generics versions, because the formulation of Dyazide resulted in variable batches that made it impossible for generic manufacturers to show that their versions were bioequivalent. 1181:

criticized the company for the "outsized compensation" of its directors. Former CEO Robert Coury received a $ 98 million 2016 pay package in spite of shareholder losses and the perceived harm to the company inflicted by the EpiPen controversies. The report urged the company's shareholders to oust all

705:

After successful lobbying from the company, in 2013, the "School Access to Emergency Epinephrine Act" became law after passing Congress with broad and bipartisan support; it protected anyone from liability if they administered epinephrine to a child in a school (previously, only trained professionals

698:, the mother of the company's CEO, Heather Bresch, had become president of the association in 2010, and shortly after had discussed donations from her "daughter's company" to the association. Manchin had been appointed to the West Virginia state school board by her husband, then-governor of the state 515:

The company had concerns about the practices of its competitors and the FDA in general, and also with regard to companies seeking to bring generic versions of Maxzide. The company hired private investigators to examine its competitors' practices, and when it found evidence of corruption, it submitted

1160:

involves misclassifying proprietary drugs as generic under the program. Under the agreement, the company agreed to pay a $ 465 million payment and to sign a corporate integrity agreement requiring it to perform better in the future; the settlement also resolved cases brought by states related to the

693:

launched a policy initiative designed to "help state boards of education as they develop student health policies regarding anaphylaxis and epinephrine auto-injector access and use," and advocated for state laws protecting schools from legal liability for stocking and using epinephrine autoinjectors.

604:

obtaining a 9.8% interest in Mylan and becoming its largest stakeholder in order to kill the deal. The parties called off the deal in February 2005. Afterwards, Icahn offered to buy Mylan for $ 5.4 billion and nominated a slate of board members to change the direction of Mylan; he won three seats in

531:

The corruption in the nascent generics industry and at the office in the FDA regulating it was widely covered in the media, and led to widespread concern among doctors and the public in the late 1980s and early 1990s that generic drugs were not really the same as the branded drugs they were meant to

1155:

over rebates paid by the company to states under the Medicaid Drug Rebate Program. Questions had been raised by Congress and others about why EpiPen had been classified as a generic rather a proprietary product in the program since 1997; generic drugs have lower rebates (13%) than proprietary drugs

1150:

According to the Department of Health and Human Services' Office of Inspector General analysis, the U.S. government may have overpaid "as much as $ 1.27 billion between 2006 and 2016" to the company for the EpiPen emergency allergy treatment. This represents three times the proposed settlement of $

1146:

In October 2016, the CEO of the company testified to Congress that Pfizer/King charged the company about $ 34.50 for one device. In September 2016, a Silicon Valley engineering consultancy performed a teardown analysis of the EpiPen and estimated the manufacturing and packaging costs at about $ 10

507:

Some generic companies committed fraud trying to bring a generic version of Dyazide. Bolar Pharmaceutical had the first generic version approved in 1987, but it turned out that Bolar had fraudulently substituted Dyazide for its own version to conduct studies that were submitted to the FDA. By 1989

1107:

reported that Bresch provided similarly dismissive responses. The reporter noted that "Those top leaders’ responses are a far cry from the message on Mylan’s website, which says that 'we challenge every member of every team to challenge the status quo,' and that 'we put people and patients first,

1102:

reported that when these concerns were brought to Robert Coury, the chairman of the board, Coury "replied that he was untroubled. He raised both his middle fingers and explained, using colorful language, that anyone criticizing Mylan, including its employees, ought to go copulate with themselves.

1074:

for people with severe allergies that made the brand "EpiPen" as identified with its product as "Kleenex" is with facial tissue. The company also successfully lobbied the FDA to broaden the label to include risk of anaphylaxis and in parallel, successfully lobbied Congress to generate legislation

511:

The company chose to develop a new version of a triamterene/hydrochlorothiazide combination drug instead of going the generic route; it developed a different, more stable formulation and used different dosages of each active ingredient (50 mg hydrochlorothiazide and 75 mg triamterene,

1090:

By the first half of 2015, Mylan had an 85% market share of such devices in the US and in that year sales reached around $ 1.5 billion and accounted for 40% of Mylan's profit. Those profits were also due in part to Mylan's continually raising the price of EpiPens starting in 2009; in 2009 the

636:

after the newspaper ran an article that was critical of the quality control procedures used at the company's Morgantown plant. The company had earlier quality control issues involving the FDA. The lawsuits were dropped in 2012 without any damages paid by the Post-Gazette, which stated "The

702:, in 2007. In a statement, the company said, "There is no truth to the suggestion that the company's efforts were anything but straightforward or that we are aware of anyone advocating inappropriately for the right of schoolchildren to have access to potential life-saving medicine." 599:

began discussing a deal in which Mylan would acquire King for $ 4 billion; Mylan wanted to expand its presence in branded pharmaceuticals and to acquire King's sales force. The deal was complicated by a number of factors, and included an SEC investigation into King's accounting and

1070:, the devices deliver about $ 1 worth of drug. At that time annual sales were around $ 200 million. Bresch, the company's CEO, saw an opportunity to increase sales through marketing and advocacy, and the company launched a marketing campaign to increase awareness of the dangers of 673:(US)/Seretide (UK) Diskus incorporating Pfizer's proprietary dry powder inhaler delivery platform. The company launched the product in the UK in 2015 and in February 2016 the FDA accepted its ANDA, putting it in line behind Hikma and Sandoz to launch a generic version in the US. 1124:. They do nothing about the high price, he said, which is still being paid by insurers, who ultimately pass the cost onto consumers. The company further responded by releasing the first authorized generic version of the EpiPen in December 2016 at a more than 50% discount. 805:

In October 2017, the company announced the launch of the first FDA-approved generic of Teva’s long-acting Copaxone. Approximately three months later, Credit Suisse analyst Vamil Divan cited IMS Health data which showed that the new generic accounted for 10% of the market.

685:

to sell EpiPens in bulk and with discounts to schools. To participate in the program schools had to agree not to buy epinephrine autoinjectors from any other company for a year, a requirement which a company spokesperson said is no longer part of its program.

1111:

In the summer of 2016, as parents prepared to send their children back to school and went to pharmacies to get new EpiPens, people began to express outrage at the cost of the EpiPen and the company was widely and harshly criticized, including criticism from

617:, for approximately $ 736 million, with the takeover including all of Matrix's subsidiary firms, for example Docpharma. It was at the time the largest-ever takeover in the Indian pharma industry and also gave access to markets in China, India, and Africa. 1202:. European manufacturers refuse to sell drugs which can be used for executions to the United States, except to distributors or users who sign legally binding agreements that the drug will not be used for executions down the delivery chain. 648:. The program requires drug companies to give rebates to states under Medicaid and the rebates are higher for new drugs than for generics; the suit said that the companies sold new drugs but paid rebates as if they were generics. 1240:

itself of $ 70 million in Mylan shares for that reason. The company said that its distribution was "legally compliant," and that their restrictions did "prohibit resale to correctional facilities for use in lethal injections."

762:

offered to buy the company for $ 40 billion; the combined companies would have been the world's largest generic company and the 9th biggest drug company in the world. In July, Teva dropped its bid for Mylan and instead acquired

4182: 1986: 3991: 1098:, mid-level executives began questioning the rate at which the company had increased and was planning to continue to increase the price of the Epi-Pen, and raising concerns that the price increases were unethical; the 1091:

wholesale price of two EpiPens was about $ 100, by July 2013 the price was about $ 265, in May 2015 it was around $ 461, and in May 2016 the price rose again to around $ 609, around a 500% jump from the price in 2009.

706:

or the affected person were allowed to administer the drug, and were open to liability), and it provided some financial incentives for schools that didn’t already stock epinephrine autoinjector to start stocking them.

1225:

without legal controls in place to prevent its use in executions, and there was "a very real risk that Mylan may soon become the go-to provider of execution drugs for states across the country". German asset manager

459:

Panoz left the company in 1969 and Puskar quit the company in 1973, as it grew and experienced financial difficulties. The board hired Roy McKnight as board chairman, who convinced Puskar to return in 1976.

1103:

Critics in Congress and on Wall Street, he said, should do the same. And regulators at the Food and Drug Administration? They, too, deserved a round of anatomically challenging self-fulfillment." The

528:, were targets of the company's initial investigation and were found to have used Maxzide to obtain their bioequivalence data, leading both companies to withdraw its generic competitor to Mylan's product. 718:

In 2013, the company acquired an Indian generic injectable drugs company, Agila Specialties Private, for $ 1.6 billion. In 2015, three plants acquired in that deal were issued warning letters by the FDA.

3152: 479:

in 1984, the company and other small generic companies gained value; in the eighteen months following passage of the law the company's earnings grew 166% to $ 12.5 million and its stock value rose 800%.

540:

In 1987, the company entered into a joint venture with Bolar to buy Somerset Pharmaceuticals; Mylan wanted access to Somersets' drug discovery capabilities as well as its new drug for Parkinson's,

2857: 2818: 4381: 637:

Post-Gazette did not find and did not intend to report that Mylan had manufactured or distributed any defective drugs. The Post-Gazette regrets if any reader of the article thought otherwise."

517: 4107: 629:

for $ 6.6 billion. The company acquired the rights to market the EpiPen in the transaction. At that time annual sales were around $ 200 million and the EpiPen had about 90% of the market.

2374: 798:

of 20 states filed a civil complaint accusing the company of a coordinated scheme to artificially maintain high prices for a generic antibiotic and diabetes drug. The complaint alleged

1108:

trusting that profits will follow'", and also noted that "The firm is a case study in the limits of what consumer and employee activism, as well as government oversight, can achieve."

3242: 5203: 750:, offering to buy $ 26 billion in shares directly from shareholders. Too few shareholders agreed to sell their stock by the deadline set in November 2015 and the effort failed. 2918: 5163: 556:

technologies, and kept it as a subsidiary. In 1999, the company renamed Bertek as Mylan Technologies Inc. (MTI). MTI eventually came to be the contract manufacturer for the

3848: 1116:, "poster boy for grasping pharma greed," letters from two senators and initiation of Congressional investigations. Mylan's pricing of the EpiPen was widely referred to as 524:'s generic drugs division and at other generic companies. Two of the companies that had gotten approval to market generic versions of Maxzide, Vitarine Pharmaceutical and 5223: 4374: 1371:

Heather Bresch was an Executive Director and the CEO of Mylan from 2012 until the Viatris combination in 2020. Robert Coury was Chairman, and Rajiv Malik was President.

2437: 2616: 5173: 2733: 2648: 863:. The company continued sales of Mylan's more than 7,500 products, including biosimilars, generics, brand and over-the-counter remedies, with brands including the 2575: 4390: 4367: 476: 3620: 5168: 738:

Also in February 2015, the company acquired Mumbai-based Famy Care and expand its presence in the market for women's contraceptives at about $ 750 million.

5228: 5198: 4183:"MYLAN's MAXZIDE IS "APPROVABLE" AT FDA: LEDERLE TO MARKET BRAND COMPETITION TO SMITHKLINE's No. 3-RANKED DYAZIDE; FINAL APPROVAL ANTICIPATED "IMMINENTLY"" 775:

In June 2015, the company agreed to work with Pulmatrix, a company with a proprietary inhaled drug delivery platform, to co-develop a product to treat for

582:, Profarmaco S.R.L., and Gyma Laboratories) also agreed to an injunction barring them from entering into similar anticompetitive agreements in the future. 4872: 4862: 4852: 4842: 4832: 4822: 4812: 4802: 4792: 809:

In May 2018, the company announced a collaboration with West Virginia University to expose children across West Virginia to STEM educational initiatives.

3743: 1987:

Mylan's Maxzide is "Approvable" at FDA: Lederle To Market Brand Competition to Smithkline's No. 3-Ranked Dyazide; Final Approval Anticipated "Imminently"

3213: 3408: 3263: 2211: 3898: 2690: 1632: 690: 4208: 3536: 2899: 2516: 2096: 1940: 791:

for $ 9.9 billion. In May 2016, the company announced it would acquire Renaissance Acquisition Holdings dermatology division for up to $ 1 billion.

5208: 5183: 4302: 3445: 1477: 3808: 1064:

devices from Merck KGaA as part of their 2007 deal; that right had formerly been held by Dey LP, a wholly owned subsidiary of Merck. According to

3943: 3421: 3189: 4281: 3827: 3719: 3111: 2711: 2671: 2630: 2231: 1388: 508:

the FDA rescinded its approval based on its suspicions and filed criminal charges against Bolar, to which Bolar eventually pled guilty in 1991.

3785: 2798: 856:

In late July 2019, the company and Pfizer announced that Pfizer would spin off and merge its off-patent medicine division, Upjohn, with Mylan.

5178: 3920: 1227: 605:

May 2005. In June, the company bought back 25% of its shares in order to fend off Icahn. In July, Icahn gave up his bid and sold his shares.

2212:"Press release: FTC Reaches Record Financial Settlement To Settle Charges of Price-fixing in Generic Drug Market | Federal Trade Commission" 2034: 1892:

John Seaman and John T. Landry. Mylan 50 Years of Unconventional Success. Mylan, in association with University Press of New England, 2011.

1169:, chair of the Senate Judiciary Committee that launched the "probe of EpiPen pricing probe in 2016, released the analysis on May 30, 2017. 1139:

and the West Virginia State Attorney General opened an investigation into whether Mylan had given the state the correct discount under the

3334: 3284: 3006: 3699: 3493: 4132: 1087:'s competing product was recalled in November 2015 and further when Teva's generic competitor was rejected by the FDA in March 2016. 560:

transdermal patch and was the first company to market generic nitroglycerin, estradiol, clonidine, and fentanyl transdermal patches.

3649: 3387: 3665: 3466: 2776: 2457: 1830: 5213: 2190: 2278: 1445: 5233: 3170: 2304: 4157: 3875: 3132: 3598: 2837: 1413: 776: 17: 2983: 2487: 3067: 2078: 368: 102: 3764: 2576:"Mylan workers overrode drug quality controls Internal report detailed 'pervasive' practice of ignoring safety procedures" 300:

Mylan went public on the OTC market in February 1973. It was listed on the NASDAQ, and its shares were a component of the

5193: 3089: 464: 3309: 2656: 311:

The company was founded in 1961 and developed and produced medicines for a wide range of medical disciplines, including

2530: 2256: 1960: 1178: 1162: 544:; the deal was completed in 1988 but its consummation was dependent on FDA approval of selegiline, which came in 1989. 3686: 3578: 2754: 1487: 5218: 1897: 1698: 845: 614: 282: 192: 1918: 5137: 3515: 3047: 2596: 1688: 1501: 1151:

465 million announced by the company in October 2016. In October 2016, the company announced a settlement with the

1076: 2961: 5188: 2842: 2418: 1430: 1128: 563:

In 1996, the company acquired UDL Laboratories, a supplier of unit dose generic medications to institutional and

293:. Through these acquisitions, the company grew from the third-largest generic and pharmaceuticals company in the 3557: 3027: 1800: 1083:

had worked with on defibrillator legislation to do so. Mylan's efforts to gain market dominance were aided when

5005: 2171: 570:

In 1998 when it was the world's second largest generics company, the company came under investigation from the

922:

The following is an illustration of the company's major mergers and acquisitions and historical predecessors:

640:

Also in 2009, the company and its subsidiary UDL agreed to pay $ 118 million to settle a suit filed under the

4544: 4260: 2878: 1482: 4081: 2819:"Mylan Completes Acquisition Of Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business" 2349: 665:

for the exclusive worldwide rights to develop, manufacture and commercialize Pfizer's generic equivalent to

4763: 4307: 3174: 3156: 2553: 1575: 1140: 837: 645: 613:

In January 2007, the company acquired a controlling interest in Matrix Laboratories, an Indian supplier of

521: 396: 1640: 375:. The facility was moved to Pennsauken, New Jersey in 1962, to Princeton, West Virginia in 1963, and then 5120: 4574: 4351: 1425: 1161:

rebates. Simultaneously with the settlement, the company also announced it was being investigated by the

1049: 886:

transaction. Pfizer shareholders owned 57% of the combined new company and Mylan shareholders owned 43%.

2057: 4569: 4235: 903: 412: 3214:"Investor Presentations – August 2020 - Path to Shareholder Value Creation VIATRIS TSR Execution Plan" 3199: 4743: 4713: 4698: 4626: 4611: 4549: 4494: 2400: 1392: 376: 1760: 802:

between six pharmaceutical firms including informal gatherings, telephone calls, and text messages.

5075: 5010: 4718: 4459: 3666:"Another reason to hate Mylan, which jacked up the price of life-saving EpiPens: It's a tax dodger" 2634: 1152: 1061: 571: 271: 2939: 229: 5158: 4925: 4646: 4636: 4631: 4489: 4429: 3604: 3247: 2967: 2580: 2559: 2442: 2333: 2017: 2012: 1214: 911: 899: 633: 424: 267: 174: 4359: 3964: 3310:"Mylan's Merger with Pfizer's Off-Patent Drug Unit Will Create 'New Champion for Global Health'" 5030: 5000: 4950: 4905: 4753: 4444: 4339: 3342: 1055: 795: 320: 821:

manufactured by the company was voluntarily recalled due to the detection of trace amounts of

5105: 4910: 4728: 4693: 4539: 4519: 2755:"How Congress, the FDA, and Sarah Jessica Parker Helped EpiPen Become a $ 1 Billion Business" 1901: 1781: 1143:

and subpoenaed the company when it refused to provide the documentation the state requested.

822: 695: 70: 2631:"Four Pharmaceutical Companies Pay $ 124 Million for Submission of False Claims to Medicaid" 1801:"The Emerging Effects of the Drug Price Competition and Patent Term Restoration Act of 1984" 1690:

Mylan: 50 Years of Unconventional Success: Making Quality Medicine Affordable and Accessible

1156:(23%), and price hikes for generic drugs cannot be passed onto states, and a common form of 840:

announced its approval of the company's Wixela Inhub, the first approved generic version of

5065: 5040: 4990: 4985: 4965: 4915: 4848: 4838: 4708: 4683: 4591: 4586: 4554: 4484: 4454: 3687:

How Congress, the FDA, and Sarah Jessica Parker Helped EpiPen Become a $ 1 Billion Business

3365:"Mylan Upjohn Merger – Pfizer Shareholders to receive 0.12 Viatris Shares per Pfizer Share" 1157: 883: 851: 759: 596: 427:

under the ticker symbol MYL. Prior to the Viatris combination, the stock was traded on the

301: 1662: 1601: 467:

in 1980 and instead chose to market their products under their own "Mylan-labeled" brand.

8: 5090: 5055: 5045: 4970: 4955: 4678: 4673: 4414: 4404: 3748: 3264:"Pfizer's Upjohn and Mylan will become Viatris. Wait, haven't we heard that name before?" 2536: 1004: 859:

In November 2019, Mylan & Upjohn announced that the name of the new company would be

732: 579: 501: 423:. Their final stock move was in 1986, when their stock became available for trade on the 199: 3641: 644:

in which Mylan/UDL and two other companies were accused of underpaying states under the

5015: 4828: 4798: 4748: 4514: 4499: 4265: 4060:"Mylan Statement on its Policy Against the Use of Mylan Products in Capital Punishment" 4059: 4041: 3904: 3881: 3499: 3393: 3095: 2944: 2782: 2465: 2327: 2310: 2284: 2261: 2237: 2196: 2145: 2118: 2040: 1966: 1924: 1859:"Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984" 1835: 1766: 1450: 1222: 1191: 525: 328: 324: 4014:"Drug company is targeted for refusing to adopt ban on distribution of execution drug" 3364: 4995: 4960: 4449: 4033: 3849:"Silicon Valley engineers figure real cost to make lifesaving auto-injector two-pack" 3671: 3562: 2355: 2150: 2063: 1893: 1812: 1714: 1694: 1455: 1446:"Mylan Laboratories To Acquire Generics Business Of Merck KGaA For 4.9 Billion Euros" 553: 379:, West Virginia, in 1965, and in 1976 it relocated its corporate headquarters to the 4261:"Why the CEO Behind the EpiPen Controversy Is on Fortune's Most Powerful Women List" 4045: 407:

On February 23, 1973, Mylan had its initial public offering (IPO), when it became a

4723: 4661: 4641: 4596: 4581: 4524: 4025: 3769: 3621:"Mylan's EpiPen price increases are Valeant-like in size, Shkreli-like in approach" 3052: 3032: 2140: 2130: 1870: 1728: 1199: 641: 493: 352: 3720:"Mylan to provide EpiPen cost assistance as CEO is asked to testify on price hike" 297:

to the second-largest generic and specialty pharmaceuticals company in the world.

5070: 4980: 4975: 4616: 4564: 4534: 4013: 2515:

Cynthia Koons and Robert Langreth for Bloomberg Businessweek. September 23, 2015

2299: 1526: 1136: 841: 666: 408: 344: 247: 83: 4900: 4606: 4303:"Generic Drug Makers Face Pricing Issues Unlike Other Pharmaceutical Companies" 3012: 2989: 2862: 2458:"Press release: Mylan Completes Acquisition of Generics Business of Merck KGaA" 2360: 2135: 1875: 1858: 1232: 1166: 1113: 1066: 895: 564: 367:

Founded in 1961, the company was first located in an abandoned skating rink in

180: 5152: 5080: 4878: 4780: 4688: 2822: 1117: 728: 416: 372: 356: 294: 106: 3409:

Press Release: King Pharmaceuticals to Acquire Meridian Medical Technologies

4858: 4282:"As rebel Mylan investors win more backing, CEO Bresch champions her board" 4037: 3724: 3541: 3537:"Mylan chairman: Drug pricing critics ought to go copulate with themselves" 2799:"UPDATED: FDA castigates three Mylan sterile drug plants in warning letter" 2154: 1816: 1210: 799: 453: 445: 388: 243: 116: 4209:"SOMERSET ELDEPRYL JUNE 5 APPROVAL CLEARS WAY FOR MYLAN/BOLAR ACQUISITION" 3112:"Look out, Teva: Mylan's Copaxone copy has already captured serious share" 2097:"Somerset Eldepryl June 5 Approval Clears Way For Mylan/Bolar Acquisition" 731:, the company acquired the generic drugs business in developed markets of 5050: 4733: 4601: 3625: 2691:"Mylan joins the Advair-copycat queue, but approval could be a long slog" 1071: 707: 699: 574:

after it raised the prices of its products, tripling them in the case of

497: 392: 332: 316: 263: 2531:"How Mylan, the EpiPen company, maneuvered to create a virtual monopoly" 2401:"Mylan Signs US$ 736-mil. Takeover Deal for India's Matrix Laboratories" 852:

Merger with Pfizer's off-patent drug business and name change to Viatris

5110: 4738: 4469: 3744:"Why Mylan's 'savings card' won't make EpiPen cheaper for all patients" 3190:"Pfizer in talks to merge off-patent drugs business with Mylan: source" 976: 626: 601: 557: 541: 488:

In the 1980s one of the most prescribed drugs in the US was Dyazide, a

384: 380: 340: 336: 305: 290: 48: 4029: 3921:"For ripping off Medicaid, EpiPen maker Mylan pays Feds $ 465 million" 2712:"Mylan may have violated antitrust law in its EpiPen sales to schools" 5060: 4930: 4703: 4668: 4529: 4504: 3828:"Upgraded EpiPens torn apart. Tech firm: "It's the same core device"" 2738: 1941:"U.s. Charges Bolar Pharmaceutical With Misrepresenting Its Products" 1857:

Boehm, Garth; Yao, Lixin; Han, Liang; Zheng, Qiang (September 2013).

1135:

program in New York to determine if the program's contracts violated

1080: 1060:

Mylan acquired the right to market and distribute the EpiPen line of

818: 575: 449: 348: 120: 3899:"Is EpiPen a Brand-Name or a Generic Drug? Mylan Casts It Both Ways" 3700:"No holds barred in Mylan's ultra-realistic peanut allergy campaign" 3422:"FDA swats down Teva's EpiPen copy, putting Mylan in cruise control" 4940: 4935: 4818: 4808: 4479: 3965:"Mylan may have overcharged U.S. for EpiPen by $ 1.27 billion: HHS" 3832: 2601: 2035:"F.D.A. Inquiry on Generic Drugs Focuses on Changes in Ingredients" 1550: 1237: 1121: 876: 764: 489: 444:

Mylan Pharmaceuticals was founded as a drug distributor in 1961 by

312: 2734:"Family matters: EpiPens had high-level help getting into schools" 5095: 4945: 4868: 4788: 4758: 4656: 4621: 4559: 4474: 4434: 4419: 4389: 4286: 3704: 3520: 3426: 3268: 3194: 3137: 3116: 3072: 2923: 2883: 2803: 2759: 2695: 1840: 1195: 1018: 872: 864: 860: 788: 779:; the product was PUR0200, a generic drug in a Pulmatrix device. 747: 286: 259: 163: 153: 3992:"EpiPen maker faces revolt over exec's $ 98 million pay package" 5100: 5035: 5025: 4920: 4651: 4464: 4409: 4334: 3809:"Mylan Investigations Mount as West Virginia Opens Fraud Probe" 3579:"People With Food Allergies Say Life-Saving Drug Too Expensive" 3450: 1206: 1084: 990: 907: 868: 670: 662: 625:

In October 2007, the company acquired the generics division of

520:, which investigated and found fraud and corruption within the 428: 420: 395:, a suburban business park located in the Pittsburgh suburb of 255: 251: 149: 3958: 3956: 3596:

Walker, Joseph; Winslow, Ron; Steele, Anne (August 30, 2016).

3385:

Parker-Pope, Tara; Peachman, Rachel Rabkin (August 22, 2016).

2940:"Why Mylan Just Lost The Largest Hostile Takeover Battle Ever" 2672:"GSK breathes freely as Mylan launches Seretide generic in UK" 2517:

How Marketing Turned the EpiPen Into a Billion-Dollar Business

2232:"Generic-Drug Maker Agrees to Settlement In Price-Fixing Case" 1075:

making EpiPens available in schools and in public places like

758:

Two weeks after the company made its first offer for Perrigo,

5115: 5085: 4509: 4439: 4424: 2419:"Mylan's Acquisition of Matrix: Business Strategy Case Study" 590: 278: 39: 3068:"Mylan snaps up dermatology biz from investors in $ 1B deal" 391:. Finally in 2004 it moved to a new office center in nearby 4895: 4082:"Milan Puskar, co-founder of Mylan, dies - Drug Store News" 3953: 3944:"Mylan Agrees to $ 465 Million EpiPen Settlement With U.S." 3876:"Mylan to Settle EpiPen Overpricing Case for $ 465 Million" 3446:"Why Did Mylan Hike EpiPen Prices 400%? Because They Could" 3335:"Pfizer to spinoff, merge off-patent drugs unit with Mylan" 2879:"Mylan buys female health businesses from Indian drugmaker" 2858:"US drugmaker Mylan to acquire Famy Care for $ 750 Million" 746:

In April 2015, the company attempted a hostile takeover of

456:

tablets as well as vitamins and other dietary supplements.

3786:"Mylan's EpiPen School Sales Trigger N.Y. Antitrust Probe" 3642:"5 Signs That EpiPen Prices Are Completely Out of Control" 3090:"20 States Accuse Generic Drug Companies of Price Fixing" 1218: 787:

In February 2016, the company announced it would acquire

710:, the father of Mylan's CEO, was a senator at that time. 218: 5204:

Companies formerly listed on the New York Stock Exchange

4326: 3388:"EpiPen Price Rise Sparks Concern for Allergy Sufferers" 277:

In 2007, the company acquired a controlling interest in

4236:"Merck KGaA sells generics unit to Mylan for $ 6.6 bln" 3467:"Cost Jumps Nearly 500-Percent For Life-Saving EpiPens" 2959:

Rockoff, Jonathan D.; Mattioli, Dana (April 22, 2015).

1165:

related to the drug rebate program. Republican Senator

285:(APIs) for generic drugs, and the generics business of 3243:"Viatris picked as new name for a merged Mylan/Upjohn" 3007:"Teva Snaps Up Allergan's Generics Arm, Dumping Mylan" 2919:"Mylan fails in $ 26 billion takeover bid for Perrigo" 2649:"Mylan acquires rights to Pfizer's inhaler technology" 2597:"It's Not Mylan's First Quality Control Beef With FDA" 2528:

Johnson, Carolyn Y.; Ho, Catherine (August 25, 2016).

2438:"Mylan buys Merck generic drug unit for $ 6.6 billion" 2112: 2110: 1502:"History of Mylan Laboratories Inc. – FundingUniverse" 281:-based Matrix Laboratories Limited, a top producer of 5164:

Defunct pharmaceutical companies of the United States

3784:

Larson, Erik; Hopkins, Jared S. (September 6, 2016).

2488:"Mylan completes acquisition of Merck's generic unit" 3807:

Feeley, Jef; Langreth, Robert (September 20, 2016).

3599:"Mylan to Launch Cheaper Generic EpiPen Alternative" 3516:"Drug Company Chairman to America: Go Fuck Yourself" 2574:

Sabatini, Patricia; Boselovic, Len (July 26, 2009).

1389:"After nearly 60 years, Mylan makes way for Viatris" 1094:

Starting in 2014, according to a 2017 report in the

1026:

Renaissance Acquisition Holdings (Dermatology div.)

661:

In 2011, the company entered into an agreement with

632:

In 2009, the company filed two lawsuits against the

3595: 3384: 2617:"Drug company Mylan, Post-Gazette resolve lawsuits" 2107: 1888: 1886: 1687:Seaman, John T.; Landry, John T. (April 10, 2012). 1478:"Pharmaceutical giants tracking Mylan's prosperity" 1418: 767:'s generic drug business for about the same price. 5224:Companies based in Washington County, Pennsylvania 3897: 3874: 3741: 3664: 3597: 3494:"Outcry Over EpiPen Prices Hasn't Made Them Lower" 3492: 3486: 3484: 3386: 3088: 3005: 2982: 2960: 2775: 2552: 2529: 2348: 2326: 2303: 2279:"Icahn Offers $ 5.4 Billion for Mylan, Drug Maker" 2277: 2230: 2189: 2119:"Recent trends in specialty pharma business model" 2056: 2033: 1959: 1917: 1759: 2727: 2725: 2709: 2573: 2511: 2509: 2507: 2505: 2503: 2501: 1831:"COMPANY NEWS; SmithKline Loses Drug Exclusivity" 691:National Association of State Boards of Education 552:The company acquired Bertek Inc. in 1993 for its 5150: 3868: 3866: 2710:Swetlitz, Ike; Silverman, Ed (August 26, 2016). 2079:"Bolar and Mylan Team to Purchase Somerset Labs" 2058:"FDA to Lift OK of Last Dyazide Generic Version" 1981: 1979: 1977: 1883: 1856: 1753: 1751: 1749: 1747: 1745: 1414:10-K for the Fiscal Year Ended December 31, 2015 741: 5174:Pharmaceutical companies disestablished in 2020 3983: 3481: 3028:"Mylan to Co-Develop Pulmatrix' COPD Candidate" 2958: 2191:"A Drug Maker Is Said to Face A Suit on Prices" 1805:Journal of Contemporary Health Law & Policy 1715:"Mylan 50 years young and still making history" 1551:"iShares Nasdaq Biotechnology Index Fund (IBB)" 681:In 2012, the company launched a program called 262:. Previously, the company was domiciled in the 3806: 3439: 3437: 3133:"Mylan and WVU announce 10 year collaboration" 2777:"Mylan Buys Drug Maker of Generic Injectables" 2722: 2498: 2250: 2248: 4391:Pharmaceutical companies of the United States 4375: 4158:"FDA approves generic forms of ciprofloxacin" 4007: 4005: 3863: 3783: 3285:"What The Pfizer-Mylan Deal Means For Pharma" 2731: 2305:"Icahn Slate Wins Seats on Blockbuster Board" 1974: 1742: 1626: 1624: 1622: 828:(NDEA) which is a probable human carcinogen. 753: 250:company. In November 2020, Mylan merged with 5169:Pharmaceutical companies established in 1961 4779: 3558:"Mylan Begins Harvesting the Crop It's Sown" 1686: 518:House Oversight and Investigations Committee 5229:Health care companies based in Pennsylvania 5199:Health care companies of the United Kingdom 3434: 3261: 2962:"Teva Offers to Buy Mylan for $ 40 Billion" 2917:Kareen Nair, Samantha (November 13, 2015). 2916: 2298: 2245: 2166: 2164: 1957: 1757: 894:On February 23, 1973, the company became a 656: 452:. In 1966, the company began manufacturing 4382: 4368: 4002: 3777: 3464: 3443: 3380: 3378: 3187: 3171:"FDA approves first generic Advair Diskus" 2984:"Teva to Buy Allergan's Generic Drug Unit" 2835: 2554:"Mylan Again Sues Pittsburgh Post-Gazette" 2183: 2181: 1915: 1619: 1131:began an investigation into the company's 831: 591:Attempted King Pharmaceuticals acquisition 228: 191:Generic and specialty pharmaceuticals and 4011: 3458: 2527: 2144: 2134: 2117:Ku, Mannching Sherry (December 1, 2015). 1874: 1633:"Milan Puskar, co-founder of Mylan, dies" 882:The deal was structured as an all-stock, 362: 258:'s off-patent medicine division, to form 3737: 3735: 3685:Matt Novak for Gizmodo. August 23, 2016 3576: 3570: 3241:Sabatini, Patricia (November 12, 2019). 3240: 3003: 2937: 2375:"US pharma major Mylan buys Matrix Labs" 2254: 2161: 1911: 1909: 1758:Freudenheim, Milt (September 10, 1989). 1630: 676: 483: 463:The company discontinued operating as a 5209:Companies formerly listed on the Nasdaq 5184:2020 disestablishments in West Virginia 4133:"Drugs@FDA: FDA Approved Drug Products" 4108:"Drugs@FDA: FDA Approved Drug Products" 3662: 3419: 3407:King Pharmaceuticals October 21, 2002. 3375: 3262:Blankenship, Kyle (November 12, 2019). 3109: 2900:"Mylan's Hostile Bid for Perrigo Fails" 2836:Tascarella, Patty (February 27, 2015). 2732:O'Donnell, Jayne (September 21, 2016). 2688: 2669: 2594: 2588: 2567: 2275: 2228: 2187: 2178: 2031: 1958:Freudenheim, Milt (February 28, 1991). 1852: 1850: 1177:In a report published on June 12, 2017 14: 5151: 4301:GATLIN, ALLISON (September 22, 2017). 4300: 4279: 3941: 3895: 3872: 3825: 3762: 3742:Carolyn Y. Johnson (August 25, 2016). 3639: 3490: 3282: 3130: 3086: 2876: 2796: 2773: 2435: 2054: 1916:Strickland, Carol (October 15, 1989). 1406: 1217:told the company that it was the only 917: 266:, with principal executive offices in 4363: 3962: 3732: 3697: 3618: 3577:Goldberg, Kenny (February 18, 2016). 3513: 3465:Bartolotta, Devin (August 18, 2016). 3444:Willingham, Emily (August 21, 2016). 2897: 2877:Nathan, Vidya L. (February 3, 2015). 2752: 2550: 2276:Pollack, Andrew (November 20, 2004). 2188:Labaton, Stephen (December 5, 1998). 1961:"Bolar Plans Guilty Plea On Generics" 1906: 1798: 1631:Dearment, Alaric (October 10, 2011). 1386: 1056:Heather Bresch § Mylan executive 1050:Epinephrine autoinjector § Price 777:chronic obstructive pulmonary disease 722: 620: 608: 535: 5179:1961 establishments in West Virginia 4233: 3918: 3663:Hiltzik, Michael (August 23, 2016). 3555: 3534: 2898:Koons, Cynthia (November 13, 2015). 2689:Helfand, Carly (February 22, 2016). 2172:"Mylan 1996 Form 10-K Annual Report" 2032:Andrews, Edmund L. (July 31, 1989). 2013:"US Judge to Rule on Drug Marketing" 2010: 1999:Approval History NDA 019129: Maxzide 1938: 1847: 1387:Gough, Paul J. (November 16, 2020). 1313: 1249: 1194:, which is approved by the state of 1079:are, and hired the same people that 991:Pfizer Respiratory Delivery Platform 906:market. In 1976, the stock moved to 713: 103:White Sulphur Springs, West Virginia 4348:Historical business data for Mylan: 3942:Tracer, Zachary (October 7, 2016). 3896:Thomas, Katie (September 2, 2016). 3763:Ramsey, Lydia (December 16, 2016). 3188:Ponnezhath, Maria (July 27, 2019). 3087:Thomas, Katie (December 15, 2016). 2938:WIECZNER, JEN (November 13, 2015). 2774:Thomas, Katie (February 27, 2013). 2551:Adams, Russell (October 30, 2009). 2055:Cimons, Marlene (August 29, 1989). 2011:Reid, Kenneth (November 17, 1987). 1919:"Bolar: A Drug Company Under Siege" 1005:Abbott Laboratories (Generics div.) 812: 782: 465:contract manufacturing organization 439: 27:Pharmaceutical company, now Viatris 24: 4669:Pharmaceutical Product Development 3826:Popken, Ben (September 30, 2016). 3765:"The $ 300 generic EpiPen is here" 3698:Bulik, Beth Snyder (May 1, 2016). 3652:from the original on May 25, 2022. 3110:Helfand, Carly (January 4, 2018). 3048:"Mylan to Acquire Meda for $ 9.9B" 3004:Somayaji, Chitra (July 27, 2015). 2255:Creswell, Julie (March 21, 2005). 2229:Labaton, Stephen (July 13, 2000). 2116: 1185: 1179:Institutional Shareholder Services 1163:Securities and Exchange Commission 25: 5245: 4318: 3873:Thomas, Katie (October 7, 2016). 3846: 2464:. October 2, 2007. Archived from 2123:Journal of Food and Drug Analysis 1939:Shaw, Donna (February 27, 1991). 1486:. August 13, 2008. Archived from 1043: 615:active pharmaceutical ingredients 419:MYLN. In 1976 the stock moved to 283:active pharmaceutical ingredients 193:active pharmaceutical ingredients 5138:List of pharmaceutical companies 4333: 4294: 4273: 4253: 4227: 4201: 4175: 4150: 4125: 4100: 4074: 4052: 3989: 3935: 3912: 3889: 3840: 3819: 3800: 3756: 3712: 3691: 3679: 3656: 3640:Tuttle, Brad (August 22, 2016). 3633: 3612: 3491:Duhigg, Charles (June 4, 2017). 3420:Helfand, Carly (March 1, 2016). 2838:"Mylan inversion deal completed" 2797:Palmer, Eric (August 18, 2015). 2324: 1172: 770: 38: 4280:Staton, Tracy (June 15, 2017). 3963:Erman, Michael (May 31, 2017). 3619:Court, Emma (August 18, 2016). 3589: 3549: 3528: 3507: 3413: 3401: 3357: 3341:. July 29, 2019. Archived from 3327: 3302: 3283:Brozak, Steve (July 29, 2019). 3276: 3255: 3234: 3206: 3181: 3163: 3145: 3124: 3103: 3080: 3060: 3040: 3020: 2997: 2975: 2952: 2931: 2910: 2891: 2870: 2850: 2843:American City Business Journals 2829: 2811: 2790: 2767: 2753:Novak, Matt (August 23, 2016). 2746: 2703: 2682: 2663: 2641: 2623: 2609: 2544: 2521: 2480: 2450: 2429: 2411: 2393: 2367: 2341: 2318: 2292: 2269: 2222: 2204: 2089: 2071: 2048: 2025: 2004: 2001:Page accessed September 8, 2016 1991: 1951: 1932: 1823: 1792: 1774: 1721: 1707: 1680: 1655: 1594: 1431:American City Business Journals 1426:"Mylan buys part of drug maker" 1129:New York State Attorney General 206: 5214:1970s initial public offerings 4012:Owen Dyer (October 24, 2014). 3919:Mole, Beth (October 7, 2016). 3131:Hudock, Megan (May 14, 2018). 2595:Edwards, Jim (July 28, 2009). 2436:Massey, Steve (May 13, 2007). 1568: 1543: 1519: 1494: 1470: 1454:. May 26, 2007. Archived from 1438: 1380: 270:, UK and a "Global Center" in 13: 1: 5234:2020 mergers and acquisitions 4545:Institute for OneWorld Health 3556:Loew, Derek (June 12, 2017). 2670:Stanton, Dan (June 8, 2015). 1663:"A Tale of Two Entrepreneurs" 1483:The Pittsburgh Tribune-Review 1374: 1366: 914:, then later back to NASDAQ. 910:and in 1986, it moved to the 742:Attempted Perrigo acquisition 4764:West Pharmaceutical Services 3514:Novak, Matt (June 5, 2017). 3175:Food and Drug Administration 3157:Food and Drug Administration 1985:Pink Sheet October 22, 1984 1141:Medicaid Drug Rebate Program 1038: 735:for $ 5.3 billion in stock. 646:Medicaid Drug Rebate Program 522:Food and Drug Administration 7: 3535:Mole, Beth (June 5, 2017). 2350:"Icahn Drops Bid for Mylan" 1863:Acta Pharmaceutica Sinica B 1729:"MYL Stock History - Mylan" 1244: 1182:of the existing directors. 10: 5250: 5194:Generic drug manufacturers 4570:McNeil Consumer Healthcare 3221:Champion For Global Health 2136:10.1016/j.jfda.2015.04.008 1876:10.1016/j.apsb.2013.07.004 1221:-approved manufacturer of 1053: 1047: 977:Merck KGaA (Generics div.) 889: 754:Attempted purchase by Teva 434: 359:, and women's healthcare. 5133: 5076:Smith, Kline & French 4888: 4772: 4627:Northwest Biotherapeutics 4612:Merrimack Pharmaceuticals 4397: 4308:Investor's Business Daily 1393:Pittsburgh Business Times 1198:for use in executions by 1190:The company manufactures 984:Bioniche Pharma Holdings 940:Somerset Pharmaceuticals 595:In 2004, the company and 213: 198: 187: 169: 159: 144: 126: 112: 89: 79: 66: 58: 46: 37: 5219:Canonsburg, Pennsylvania 2635:US Department of Justice 1799:Lewis, Ralph A. (1992). 1602:"Therapeutic Innovation" 1153:US Department of Justice 1062:epinephrine autoinjector 657:Generic Advair agreement 651: 585: 572:Federal Trade Commission 547: 475:With the passage of the 470: 402: 272:Canonsburg, Pennsylvania 3605:The Wall Street Journal 3248:Pittsburgh Post-Gazette 2968:The Wall Street Journal 2581:Pittsburgh Post-Gazette 2560:The Wall Street Journal 2443:Pittsburgh Post-Gazette 2018:The Journal of Commerce 1786:www.thepharmaletter.com 1506:www.fundinguniverse.com 1205:In September 2014, the 1127:In September 2016, the 912:New York Stock Exchange 900:initial public offering 832:Generic Advair approval 800:price collusion schemes 796:State attorneys general 727:In February 2015, in a 634:Pittsburgh Post-Gazette 425:New York Stock Exchange 268:Hatfield, Hertfordshire 175:Hatfield, Hertfordshire 5189:Life sciences industry 5001:Leiner Health Products 4445:Amneal Pharmaceuticals 4137:www.accessdata.fda.gov 4112:www.accessdata.fda.gov 2676:in-Pharma Technologist 794:In December 2016, the 689:In December 2012, the 363:Corporate headquarters 130:November 16, 2020 4555:Johnson & Johnson 2494:. September 30, 2008. 1945:Philadelphia Inquirer 1761:"Exposing the F.D.A." 1490:on September 8, 2008. 1301:Cipro (Ciprofloxacin) 836:In January 2019, the 677:EpiPen4Schools launch 484:Dyazide & Maxzide 369:White Sulphur Springs 132:; 3 years ago 18:Mylan Pharmaceuticals 4849:Jazz Pharmaceuticals 4839:Horizon Therapeutics 4709:Sarepta Therapeutics 4684:Proteon Therapeutics 4679:Procter & Gamble 4592:Melinta Therapeutics 4485:Bristol Myers Squibb 4342:at Wikimedia Commons 3371:. November 17, 2020. 3056:. February 11, 2016. 2825:. February 27, 2015. 2218:. November 29, 2000. 2085:. November 14, 1988. 1782:"Mylan Laboratories" 1458:on February 24, 2008 1434:. December 18, 2006. 1268:Penicillin G tablets 1158:pharmaceutical fraud 970:Matrix Laboratories 884:Reverse Morris Trust 826:-nitrosodiethylamine 760:Teva Pharmaceuticals 597:King Pharmaceuticals 302:NASDAQ Biotechnology 5056:Repros Therapeutics 4971:Forest Laboratories 4956:Cutter Laboratories 4674:Prasco Laboratories 4415:Acorda Therapeutics 4405:Abbott Laboratories 3749:The Washington Post 3177:. January 30, 2019. 3159:. December 4, 2018. 2866:. February 3, 2015. 2637:. October 19, 2009. 2537:The Chicago Tribune 2328:"Survival Strategy" 2257:"Icahn the Spoiler" 1667:www.wvexecutive.com 918:Acquisition history 733:Abbott Laboratories 580:Cambrex Corporation 502:hydrochlorothiazide 34: 5016:Miles Laboratories 5006:Martek Biosciences 4829:Endo International 4749:Ventria Bioscience 4515:Danco Laboratories 4234:Kusjanto, Mantik. 4189:. October 22, 1984 4088:. October 10, 2011 3905:The New York Times 3882:The New York Times 3851:. The Mercury News 3728:. August 25, 2016. 3500:The New York Times 3394:The New York Times 3096:The New York Times 2783:The New York Times 2407:. August 28, 2006. 2379:The Economic Times 2311:The New York Times 2285:The New York Times 2238:The New York Times 2197:The New York Times 2041:The New York Times 1967:The New York Times 1925:The New York Times 1843:. August 22, 1987. 1836:The New York Times 1767:The New York Times 1451:Medical News Today 1223:rocuronium bromide 1192:rocuronium bromide 998:Agila Specialties 926:Mylan Acquisitions 723:Abbott acquisition 621:EpiPen acquisition 609:Matrix acquisition 536:Acquisitions begin 526:Par Pharmaceutical 349:infectious disease 32: 5146: 5145: 5129: 5128: 4961:DNAPrint Genomics 4450:Avax Technologies 4338:Media related to 4030:10.1136/bmj.g6452 3672:Los Angeles Times 3583:KPBS Public Media 3202:on July 27, 2019. 3173:(Press release). 3155:(Press release). 2821:(Press release). 2653:drugstorenews.com 2633:(Press release). 2381:. August 29, 2006 2356:Los Angeles Times 2325:Lazo, Shirley A. 2064:Los Angeles Times 1582:. October 5, 2017 1580:marketrealist.com 1364: 1363: 1314:Branded Medicines 1311: 1310: 1250:Generic Medicines 1029: 1023: 1015: 1009: 1001: 995: 987: 981: 973: 967: 961: 958:UDL Laboratories 955: 949: 943: 937: 714:Agila acquisition 554:transdermal patch 415:market under the 237: 236: 74:(under Dutch law) 16:(Redirected from 5241: 4777: 4776: 4724:Tec Laboratories 4597:Melior Discovery 4582:Kinetic Concepts 4525:Galena Biopharma 4384: 4377: 4370: 4361: 4360: 4337: 4330: 4329: 4327:Official website 4313: 4312: 4298: 4292: 4291: 4277: 4271: 4270: 4257: 4251: 4250: 4248: 4246: 4231: 4225: 4224: 4222: 4220: 4205: 4199: 4198: 4196: 4194: 4179: 4173: 4172: 4170: 4168: 4154: 4148: 4147: 4145: 4143: 4129: 4123: 4122: 4120: 4118: 4104: 4098: 4097: 4095: 4093: 4078: 4072: 4071: 4069: 4067: 4056: 4050: 4049: 4009: 4000: 3999: 3987: 3981: 3980: 3978: 3976: 3960: 3951: 3950: 3939: 3933: 3932: 3930: 3928: 3916: 3910: 3909: 3901: 3893: 3887: 3886: 3878: 3870: 3861: 3860: 3858: 3856: 3844: 3838: 3837: 3823: 3817: 3816: 3804: 3798: 3797: 3795: 3793: 3781: 3775: 3774: 3770:Business Insider 3760: 3754: 3753: 3739: 3730: 3729: 3716: 3710: 3709: 3695: 3689: 3683: 3677: 3676: 3668: 3660: 3654: 3653: 3637: 3631: 3630: 3616: 3610: 3609: 3601: 3593: 3587: 3586: 3574: 3568: 3567: 3553: 3547: 3546: 3532: 3526: 3525: 3511: 3505: 3504: 3496: 3488: 3479: 3478: 3476: 3474: 3462: 3456: 3455: 3441: 3432: 3431: 3417: 3411: 3405: 3399: 3398: 3390: 3382: 3373: 3372: 3361: 3355: 3354: 3352: 3350: 3345:on July 29, 2019 3331: 3325: 3324: 3322: 3320: 3306: 3300: 3299: 3297: 3295: 3280: 3274: 3273: 3259: 3253: 3252: 3238: 3232: 3231: 3229: 3227: 3218: 3210: 3204: 3203: 3198:. Archived from 3185: 3179: 3178: 3167: 3161: 3160: 3149: 3143: 3142: 3128: 3122: 3121: 3107: 3101: 3100: 3092: 3084: 3078: 3077: 3064: 3058: 3057: 3053:Mary Ann Liebert 3044: 3038: 3037: 3036:. June 16, 2015. 3033:Mary Ann Liebert 3024: 3018: 3017: 3009: 3001: 2995: 2994: 2993:. July 27, 2015. 2986: 2979: 2973: 2972: 2964: 2956: 2950: 2949: 2935: 2929: 2928: 2914: 2908: 2907: 2895: 2889: 2888: 2874: 2868: 2867: 2854: 2848: 2847: 2833: 2827: 2826: 2815: 2809: 2808: 2794: 2788: 2787: 2779: 2771: 2765: 2764: 2750: 2744: 2743: 2729: 2720: 2719: 2707: 2701: 2700: 2686: 2680: 2679: 2667: 2661: 2660: 2655:. Archived from 2645: 2639: 2638: 2627: 2621: 2620: 2613: 2607: 2606: 2592: 2586: 2585: 2571: 2565: 2564: 2556: 2548: 2542: 2541: 2533: 2525: 2519: 2513: 2496: 2495: 2484: 2478: 2477: 2475: 2473: 2468:on June 19, 2018 2454: 2448: 2447: 2433: 2427: 2426: 2415: 2409: 2408: 2397: 2391: 2390: 2388: 2386: 2371: 2365: 2364: 2363:. July 29, 2005. 2352: 2345: 2339: 2338: 2330: 2322: 2316: 2315: 2307: 2302:(May 12, 2005). 2296: 2290: 2289: 2281: 2273: 2267: 2266: 2252: 2243: 2242: 2234: 2226: 2220: 2219: 2208: 2202: 2201: 2193: 2185: 2176: 2175: 2168: 2159: 2158: 2148: 2138: 2114: 2105: 2104: 2103:. June 12, 1989. 2093: 2087: 2086: 2075: 2069: 2068: 2060: 2052: 2046: 2045: 2037: 2029: 2023: 2022: 2008: 2002: 1995: 1989: 1983: 1972: 1971: 1963: 1955: 1949: 1948: 1936: 1930: 1929: 1921: 1913: 1904: 1890: 1881: 1880: 1878: 1854: 1845: 1844: 1827: 1821: 1820: 1796: 1790: 1789: 1778: 1772: 1771: 1763: 1755: 1740: 1739: 1737: 1735: 1725: 1719: 1718: 1711: 1705: 1704: 1684: 1678: 1677: 1675: 1673: 1659: 1653: 1652: 1650: 1648: 1639:. Archived from 1628: 1617: 1616: 1614: 1612: 1598: 1592: 1591: 1589: 1587: 1576:"Market Realist" 1572: 1566: 1565: 1563: 1561: 1547: 1541: 1540: 1538: 1536: 1523: 1517: 1516: 1514: 1512: 1498: 1492: 1491: 1474: 1468: 1467: 1465: 1463: 1442: 1436: 1435: 1422: 1416: 1410: 1404: 1403: 1401: 1399: 1384: 1327:Year Introduced 1318: 1317: 1263:Year Introduced 1254: 1253: 1236: 1200:lethal injection 1147:for a two-pack. 1027: 1021: 1013: 1007: 999: 993: 985: 979: 971: 965: 959: 953: 947: 941: 935: 813:Valsartan recall 783:Meda acquisition 642:False Claims Act 494:combination drug 477:Hatch-Waxman Act 440:Founding to 1980 353:gastroenterology 233: 232: 225: 222: 220: 140: 138: 133: 100: 98: 75: 42: 35: 31: 21: 5249: 5248: 5244: 5243: 5242: 5240: 5239: 5238: 5149: 5148: 5147: 5142: 5125: 5071:Schering-Plough 4981:ImClone Systems 4884: 4768: 4617:Myriad Genetics 4607:Merck & Co. 4565:Janssen Biotech 4535:Gilead Sciences 4393: 4388: 4356: 4325: 4324: 4321: 4316: 4299: 4295: 4278: 4274: 4259: 4258: 4254: 4244: 4242: 4232: 4228: 4218: 4216: 4215:. June 12, 1989 4207: 4206: 4202: 4192: 4190: 4181: 4180: 4176: 4166: 4164: 4156: 4155: 4151: 4141: 4139: 4131: 4130: 4126: 4116: 4114: 4106: 4105: 4101: 4091: 4089: 4086:Drug Store News 4080: 4079: 4075: 4065: 4063: 4058: 4057: 4053: 4010: 4003: 3988: 3984: 3974: 3972: 3961: 3954: 3940: 3936: 3926: 3924: 3917: 3913: 3894: 3890: 3871: 3864: 3854: 3852: 3847:Tracy, Seipel. 3845: 3841: 3824: 3820: 3805: 3801: 3791: 3789: 3782: 3778: 3761: 3757: 3740: 3733: 3718: 3717: 3713: 3696: 3692: 3684: 3680: 3661: 3657: 3638: 3634: 3617: 3613: 3594: 3590: 3575: 3571: 3554: 3550: 3533: 3529: 3512: 3508: 3489: 3482: 3472: 3470: 3469:. CBS Baltimore 3463: 3459: 3442: 3435: 3418: 3414: 3406: 3402: 3383: 3376: 3363: 3362: 3358: 3348: 3346: 3333: 3332: 3328: 3318: 3316: 3308: 3307: 3303: 3293: 3291: 3281: 3277: 3260: 3256: 3239: 3235: 3225: 3223: 3216: 3212: 3211: 3207: 3186: 3182: 3169: 3168: 3164: 3151: 3150: 3146: 3129: 3125: 3108: 3104: 3085: 3081: 3076:. May 13, 2016. 3066: 3065: 3061: 3046: 3045: 3041: 3026: 3025: 3021: 3002: 2998: 2981: 2980: 2976: 2957: 2953: 2936: 2932: 2915: 2911: 2896: 2892: 2875: 2871: 2856: 2855: 2851: 2834: 2830: 2817: 2816: 2812: 2795: 2791: 2772: 2768: 2751: 2747: 2730: 2723: 2708: 2704: 2687: 2683: 2668: 2664: 2659:on May 9, 2015. 2647: 2646: 2642: 2629: 2628: 2624: 2615: 2614: 2610: 2593: 2589: 2572: 2568: 2549: 2545: 2526: 2522: 2514: 2499: 2486: 2485: 2481: 2471: 2469: 2456: 2455: 2451: 2434: 2430: 2417: 2416: 2412: 2399: 2398: 2394: 2384: 2382: 2373: 2372: 2368: 2347: 2346: 2342: 2323: 2319: 2297: 2293: 2274: 2270: 2253: 2246: 2227: 2223: 2210: 2209: 2205: 2186: 2179: 2170: 2169: 2162: 2115: 2108: 2095: 2094: 2090: 2077: 2076: 2072: 2053: 2049: 2030: 2026: 2009: 2005: 1996: 1992: 1984: 1975: 1956: 1952: 1937: 1933: 1914: 1907: 1891: 1884: 1855: 1848: 1829: 1828: 1824: 1797: 1793: 1780: 1779: 1775: 1756: 1743: 1733: 1731: 1727: 1726: 1722: 1713: 1712: 1708: 1701: 1685: 1681: 1671: 1669: 1661: 1660: 1656: 1646: 1644: 1637:Drug Store News 1629: 1620: 1610: 1608: 1600: 1599: 1595: 1585: 1583: 1574: 1573: 1569: 1559: 1557: 1549: 1548: 1544: 1534: 1532: 1525: 1524: 1520: 1510: 1508: 1500: 1499: 1495: 1476: 1475: 1471: 1461: 1459: 1444: 1443: 1439: 1424: 1423: 1419: 1411: 1407: 1397: 1395: 1385: 1381: 1377: 1369: 1316: 1252: 1247: 1230: 1188: 1186:Execution drugs 1175: 1058: 1052: 1046: 1041: 1036: 1035: 1034: 927: 920: 892: 854: 842:GlaxoSmithKline 834: 815: 785: 773: 756: 744: 725: 716: 679: 667:GlaxoSmithKline 659: 654: 623: 611: 593: 588: 550: 538: 486: 473: 442: 437: 411:company on the 409:publicly traded 405: 365: 345:pain management 321:antiretrovirals 248:pharmaceuticals 227: 217: 183: 177: 136: 134: 131: 119: 96: 94: 84:Pharmaceuticals 73: 51: 28: 23: 22: 15: 12: 11: 5: 5247: 5237: 5236: 5231: 5226: 5221: 5216: 5211: 5206: 5201: 5196: 5191: 5186: 5181: 5176: 5171: 5166: 5161: 5159:Tax inversions 5144: 5143: 5141: 5140: 5134: 5131: 5130: 5127: 5126: 5124: 5123: 5118: 5113: 5108: 5103: 5098: 5093: 5088: 5083: 5078: 5073: 5068: 5063: 5058: 5053: 5048: 5043: 5038: 5033: 5028: 5023: 5018: 5013: 5008: 5003: 4998: 4993: 4988: 4983: 4978: 4973: 4968: 4963: 4958: 4953: 4948: 4943: 4938: 4933: 4928: 4923: 4918: 4913: 4908: 4903: 4901:Allergan, Inc. 4898: 4892: 4890: 4886: 4885: 4883: 4882: 4881:(Canada, 2010) 4876: 4866: 4856: 4846: 4836: 4826: 4816: 4806: 4796: 4785: 4783: 4774: 4770: 4769: 4767: 4766: 4761: 4756: 4751: 4746: 4741: 4736: 4731: 4726: 4721: 4716: 4711: 4706: 4701: 4696: 4691: 4686: 4681: 4676: 4671: 4666: 4665: 4664: 4659: 4649: 4644: 4639: 4634: 4632:Norwich Pharma 4629: 4624: 4619: 4614: 4609: 4604: 4599: 4594: 4589: 4584: 4579: 4578: 4577: 4572: 4567: 4562: 4552: 4547: 4542: 4537: 4532: 4527: 4522: 4517: 4512: 4507: 4502: 4497: 4492: 4487: 4482: 4477: 4472: 4467: 4462: 4457: 4452: 4447: 4442: 4437: 4432: 4427: 4422: 4417: 4412: 4407: 4401: 4399: 4395: 4394: 4387: 4386: 4379: 4372: 4364: 4358: 4357: 4355: 4354: 4349: 4345: 4343: 4331: 4320: 4319:External links 4317: 4315: 4314: 4293: 4272: 4252: 4226: 4200: 4174: 4149: 4124: 4099: 4073: 4051: 4024:(349): g6452. 4001: 3982: 3952: 3934: 3923:. Ars Technica 3911: 3888: 3862: 3839: 3818: 3813:Bloomberg News 3799: 3776: 3755: 3731: 3711: 3690: 3678: 3655: 3632: 3611: 3588: 3569: 3548: 3527: 3506: 3480: 3457: 3433: 3412: 3400: 3374: 3369:Mr. Virk Media 3356: 3326: 3301: 3275: 3254: 3233: 3205: 3180: 3162: 3144: 3123: 3102: 3079: 3059: 3039: 3019: 3013:Bloomberg News 2996: 2990:Bloomberg News 2974: 2951: 2930: 2909: 2890: 2869: 2863:Times Internet 2849: 2828: 2810: 2789: 2766: 2745: 2721: 2702: 2681: 2662: 2640: 2622: 2608: 2587: 2566: 2543: 2520: 2497: 2479: 2449: 2428: 2410: 2392: 2366: 2361:Bloomberg News 2340: 2317: 2291: 2268: 2244: 2221: 2203: 2177: 2160: 2129:(4): 595–608. 2106: 2088: 2070: 2047: 2024: 2003: 1990: 1973: 1950: 1931: 1905: 1882: 1869:(5): 297–311. 1846: 1822: 1811:(1): 361–378. 1791: 1773: 1741: 1720: 1706: 1699: 1679: 1654: 1643:on May 3, 2017 1618: 1593: 1567: 1542: 1518: 1493: 1469: 1437: 1417: 1405: 1378: 1376: 1373: 1368: 1365: 1362: 1361: 1358: 1355: 1351: 1350: 1347: 1344: 1340: 1339: 1336: 1335:Blood pressure 1333: 1329: 1328: 1325: 1322: 1315: 1312: 1309: 1308: 1305: 1302: 1298: 1297: 1294: 1291: 1287: 1286: 1283: 1280: 1276: 1275: 1272: 1269: 1265: 1264: 1261: 1258: 1251: 1248: 1246: 1243: 1187: 1184: 1174: 1171: 1167:Chuck Grassley 1133:EpiPen4Schools 1114:Martin Shkreli 1096:New York Times 1077:defibrillators 1067:Bloomberg News 1045: 1044:EpiPen pricing 1042: 1040: 1037: 1033: 1032: 1031: 1030: 1024: 1016: 1010: 1002: 996: 988: 982: 974: 968: 962: 956: 950: 946:Dow B. Hickam 944: 936:(Founded 1961) 929: 928: 925: 924: 919: 916: 902:(IPO), on the 896:public company 891: 888: 853: 850: 833: 830: 814: 811: 784: 781: 772: 769: 755: 752: 743: 740: 724: 721: 715: 712: 683:EpiPen4Schools 678: 675: 658: 655: 653: 650: 622: 619: 610: 607: 592: 589: 587: 584: 565:long-term care 549: 546: 537: 534: 485: 482: 472: 469: 441: 438: 436: 433: 404: 401: 397:Cecil Township 364: 361: 355:, diabetology/ 325:cardiovascular 246:and specialty 235: 234: 215: 211: 210: 202: 196: 195: 189: 185: 184: 181:United Kingdom 179: 173: 171: 167: 166: 161: 157: 156: 146: 142: 141: 128: 124: 123: 114: 110: 109: 91: 87: 86: 81: 77: 76: 68: 64: 63: 60: 56: 55: 52: 47: 44: 43: 26: 9: 6: 4: 3: 2: 5246: 5235: 5232: 5230: 5227: 5225: 5222: 5220: 5217: 5215: 5212: 5210: 5207: 5205: 5202: 5200: 5197: 5195: 5192: 5190: 5187: 5185: 5182: 5180: 5177: 5175: 5172: 5170: 5167: 5165: 5162: 5160: 5157: 5156: 5154: 5139: 5136: 5135: 5132: 5122: 5119: 5117: 5114: 5112: 5109: 5107: 5104: 5102: 5099: 5097: 5094: 5092: 5089: 5087: 5084: 5082: 5081:Sterling Drug 5079: 5077: 5074: 5072: 5069: 5067: 5064: 5062: 5059: 5057: 5054: 5052: 5049: 5047: 5044: 5042: 5039: 5037: 5034: 5032: 5029: 5027: 5024: 5022: 5019: 5017: 5014: 5012: 5009: 5007: 5004: 5002: 4999: 4997: 4994: 4992: 4989: 4987: 4984: 4982: 4979: 4977: 4974: 4972: 4969: 4967: 4964: 4962: 4959: 4957: 4954: 4952: 4949: 4947: 4944: 4942: 4939: 4937: 4934: 4932: 4929: 4927: 4924: 4922: 4919: 4917: 4914: 4912: 4909: 4907: 4904: 4902: 4899: 4897: 4894: 4893: 4891: 4887: 4880: 4879:Bausch Health 4877: 4874: 4870: 4867: 4864: 4860: 4857: 4854: 4850: 4847: 4844: 4840: 4837: 4834: 4830: 4827: 4824: 4820: 4817: 4814: 4810: 4807: 4804: 4800: 4797: 4794: 4790: 4787: 4786: 4784: 4782: 4781:Tax inversion 4778: 4775: 4771: 4765: 4762: 4760: 4757: 4755: 4752: 4750: 4747: 4745: 4742: 4740: 4737: 4735: 4732: 4730: 4727: 4725: 4722: 4720: 4717: 4715: 4712: 4710: 4707: 4705: 4702: 4700: 4697: 4695: 4692: 4690: 4689:Purdue Pharma 4687: 4685: 4682: 4680: 4677: 4675: 4672: 4670: 4667: 4663: 4660: 4658: 4655: 4654: 4653: 4650: 4648: 4645: 4643: 4640: 4638: 4635: 4633: 4630: 4628: 4625: 4623: 4620: 4618: 4615: 4613: 4610: 4608: 4605: 4603: 4600: 4598: 4595: 4593: 4590: 4588: 4585: 4583: 4580: 4576: 4573: 4571: 4568: 4566: 4563: 4561: 4558: 4557: 4556: 4553: 4551: 4548: 4546: 4543: 4541: 4538: 4536: 4533: 4531: 4528: 4526: 4523: 4521: 4518: 4516: 4513: 4511: 4508: 4506: 4503: 4501: 4498: 4496: 4493: 4491: 4488: 4486: 4483: 4481: 4478: 4476: 4473: 4471: 4468: 4466: 4463: 4461: 4458: 4456: 4453: 4451: 4448: 4446: 4443: 4441: 4438: 4436: 4433: 4431: 4428: 4426: 4423: 4421: 4418: 4416: 4413: 4411: 4408: 4406: 4403: 4402: 4400: 4396: 4392: 4385: 4380: 4378: 4373: 4371: 4366: 4365: 4362: 4353: 4350: 4347: 4346: 4344: 4341: 4336: 4332: 4328: 4323: 4322: 4310: 4309: 4304: 4297: 4289: 4288: 4283: 4276: 4268: 4267: 4262: 4256: 4241: 4237: 4230: 4214: 4210: 4204: 4188: 4184: 4178: 4163: 4159: 4153: 4138: 4134: 4128: 4113: 4109: 4103: 4087: 4083: 4077: 4061: 4055: 4047: 4043: 4039: 4035: 4031: 4027: 4023: 4019: 4015: 4008: 4006: 3997: 3993: 3986: 3970: 3966: 3959: 3957: 3948: 3947:Bloomberg.com 3945: 3938: 3922: 3915: 3907: 3906: 3900: 3892: 3884: 3883: 3877: 3869: 3867: 3850: 3843: 3835: 3834: 3829: 3822: 3814: 3810: 3803: 3787: 3780: 3772: 3771: 3766: 3759: 3751: 3750: 3745: 3738: 3736: 3727: 3726: 3721: 3715: 3707: 3706: 3701: 3694: 3688: 3682: 3674: 3673: 3667: 3659: 3651: 3647: 3643: 3636: 3628: 3627: 3622: 3615: 3607: 3606: 3600: 3592: 3584: 3580: 3573: 3565: 3564: 3559: 3552: 3544: 3543: 3538: 3531: 3523: 3522: 3517: 3510: 3502: 3501: 3495: 3487: 3485: 3468: 3461: 3453: 3452: 3447: 3440: 3438: 3429: 3428: 3423: 3416: 3410: 3404: 3396: 3395: 3389: 3381: 3379: 3370: 3366: 3360: 3344: 3340: 3336: 3330: 3315: 3311: 3305: 3290: 3286: 3279: 3271: 3270: 3265: 3258: 3250: 3249: 3244: 3237: 3222: 3215: 3209: 3201: 3197: 3196: 3191: 3184: 3176: 3172: 3166: 3158: 3154: 3148: 3140: 3139: 3134: 3127: 3119: 3118: 3113: 3106: 3098: 3097: 3091: 3083: 3075: 3074: 3069: 3063: 3055: 3054: 3049: 3043: 3035: 3034: 3029: 3023: 3015: 3014: 3008: 3000: 2992: 2991: 2985: 2978: 2970: 2969: 2963: 2955: 2947: 2946: 2941: 2934: 2926: 2925: 2920: 2913: 2905: 2901: 2894: 2886: 2885: 2880: 2873: 2865: 2864: 2859: 2853: 2845: 2844: 2839: 2832: 2824: 2823:Business Wire 2820: 2814: 2806: 2805: 2800: 2793: 2785: 2784: 2778: 2770: 2762: 2761: 2756: 2749: 2741: 2740: 2735: 2728: 2726: 2717: 2713: 2706: 2698: 2697: 2692: 2685: 2677: 2673: 2666: 2658: 2654: 2650: 2644: 2636: 2632: 2626: 2618: 2612: 2604: 2603: 2598: 2591: 2583: 2582: 2577: 2570: 2562: 2561: 2555: 2547: 2539: 2538: 2532: 2524: 2518: 2512: 2510: 2508: 2506: 2504: 2502: 2493: 2489: 2483: 2467: 2463: 2459: 2453: 2445: 2444: 2439: 2432: 2424: 2420: 2414: 2406: 2402: 2396: 2380: 2376: 2370: 2362: 2358: 2357: 2351: 2344: 2336: 2335: 2329: 2321: 2313: 2312: 2306: 2301: 2300:O'keefe, Eric 2295: 2287: 2286: 2280: 2272: 2264: 2263: 2258: 2251: 2249: 2240: 2239: 2233: 2225: 2217: 2213: 2207: 2199: 2198: 2192: 2184: 2182: 2173: 2167: 2165: 2156: 2152: 2147: 2142: 2137: 2132: 2128: 2124: 2120: 2113: 2111: 2102: 2098: 2092: 2084: 2080: 2074: 2066: 2065: 2059: 2051: 2043: 2042: 2036: 2028: 2020: 2019: 2014: 2007: 2000: 1994: 1988: 1982: 1980: 1978: 1969: 1968: 1962: 1954: 1946: 1942: 1935: 1927: 1926: 1920: 1912: 1910: 1903: 1899: 1898:9781611682700 1895: 1889: 1887: 1877: 1872: 1868: 1864: 1860: 1853: 1851: 1842: 1838: 1837: 1832: 1826: 1818: 1814: 1810: 1806: 1802: 1795: 1787: 1783: 1777: 1769: 1768: 1762: 1754: 1752: 1750: 1748: 1746: 1730: 1724: 1716: 1710: 1702: 1700:9781611682700 1696: 1692: 1691: 1683: 1668: 1664: 1658: 1642: 1638: 1634: 1627: 1625: 1623: 1607: 1606:www.mylan.com 1603: 1597: 1581: 1577: 1571: 1556: 1552: 1546: 1531: 1528: 1522: 1507: 1503: 1497: 1489: 1485: 1484: 1479: 1473: 1457: 1453: 1452: 1447: 1441: 1433: 1432: 1427: 1421: 1415: 1409: 1394: 1390: 1383: 1379: 1372: 1359: 1356: 1353: 1352: 1348: 1345: 1342: 1341: 1337: 1334: 1331: 1330: 1326: 1323: 1320: 1319: 1306: 1303: 1300: 1299: 1295: 1292: 1289: 1288: 1284: 1281: 1278: 1277: 1273: 1270: 1267: 1266: 1262: 1259: 1256: 1255: 1242: 1239: 1234: 1229: 1224: 1220: 1216: 1213:organisation 1212: 1208: 1203: 1201: 1197: 1193: 1183: 1180: 1173:Executive pay 1170: 1168: 1164: 1159: 1154: 1148: 1144: 1142: 1138: 1137:antitrust law 1134: 1130: 1125: 1123: 1119: 1118:price gouging 1115: 1109: 1106: 1101: 1097: 1092: 1088: 1086: 1082: 1078: 1073: 1069: 1068: 1063: 1057: 1051: 1025: 1020: 1017: 1011: 1006: 1003: 997: 992: 989: 983: 978: 975: 969: 964:Penederm Inc 963: 957: 951: 945: 939: 938: 934: 931: 930: 923: 915: 913: 909: 905: 901: 897: 887: 885: 880: 878: 874: 870: 866: 862: 857: 849: 847: 846:Advair Diskus 843: 839: 829: 827: 825: 820: 810: 807: 803: 801: 797: 792: 790: 780: 778: 771:New COPD drug 768: 766: 761: 751: 749: 739: 736: 734: 730: 729:tax inversion 720: 711: 709: 703: 701: 697: 696:Gayle Manchin 692: 687: 684: 674: 672: 668: 664: 649: 647: 643: 638: 635: 630: 628: 618: 616: 606: 603: 598: 583: 581: 577: 573: 568: 566: 561: 559: 555: 545: 543: 533: 529: 527: 523: 519: 513: 509: 505: 503: 499: 495: 491: 481: 478: 468: 466: 461: 457: 455: 451: 447: 432: 430: 426: 422: 418: 417:ticker symbol 414: 410: 400: 398: 394: 390: 386: 382: 378: 374: 373:West Virginia 370: 360: 358: 357:endocrinology 354: 350: 346: 342: 338: 334: 330: 326: 322: 318: 314: 309: 307: 303: 298: 296: 295:United States 292: 288: 284: 280: 275: 273: 269: 265: 261: 257: 253: 249: 245: 242:was a global 241: 231: 224: 216: 212: 209: 208: 203: 201: 197: 194: 190: 186: 182: 176: 172: 168: 165: 162: 158: 155: 151: 147: 143: 129: 125: 122: 118: 115: 111: 108: 107:United States 104: 92: 88: 85: 82: 78: 72: 69: 65: 61: 57: 53: 50: 45: 41: 36: 30: 19: 5020: 4859:Mallinckrodt 4744:Upsher-Smith 4575:Ortho-McNeil 4306: 4296: 4285: 4275: 4264: 4255: 4243:. Retrieved 4239: 4229: 4217:. Retrieved 4212: 4203: 4191:. Retrieved 4186: 4177: 4165:. Retrieved 4161: 4152: 4140:. Retrieved 4136: 4127: 4115:. Retrieved 4111: 4102: 4090:. Retrieved 4085: 4076: 4064:. Retrieved 4054: 4021: 4017: 3995: 3990:Egan, Matt. 3985: 3973:. Retrieved 3968: 3946: 3937: 3925:. Retrieved 3914: 3903: 3891: 3880: 3853:. Retrieved 3842: 3831: 3821: 3812: 3802: 3792:September 7, 3790:. Retrieved 3779: 3768: 3758: 3747: 3725:The Guardian 3723: 3714: 3703: 3693: 3681: 3670: 3658: 3645: 3635: 3624: 3614: 3603: 3591: 3582: 3572: 3561: 3551: 3542:Ars Technica 3540: 3530: 3519: 3509: 3498: 3471:. Retrieved 3460: 3449: 3425: 3415: 3403: 3392: 3368: 3359: 3347:. Retrieved 3343:the original 3338: 3329: 3317:. Retrieved 3313: 3304: 3294:December 10, 3292:. Retrieved 3288: 3278: 3267: 3257: 3246: 3236: 3224:. Retrieved 3220: 3208: 3200:the original 3193: 3183: 3165: 3147: 3136: 3126: 3115: 3105: 3094: 3082: 3071: 3062: 3051: 3042: 3031: 3022: 3011: 2999: 2988: 2977: 2966: 2954: 2943: 2933: 2922: 2912: 2903: 2893: 2882: 2872: 2861: 2852: 2841: 2831: 2813: 2802: 2792: 2781: 2769: 2758: 2748: 2737: 2716:PBS Newshour 2715: 2705: 2694: 2684: 2675: 2665: 2657:the original 2652: 2643: 2625: 2611: 2600: 2590: 2579: 2569: 2558: 2546: 2535: 2523: 2491: 2482: 2472:September 8, 2470:. Retrieved 2466:the original 2461: 2452: 2441: 2431: 2422: 2413: 2404: 2395: 2383:. Retrieved 2378: 2369: 2354: 2343: 2332: 2320: 2309: 2294: 2283: 2271: 2260: 2236: 2224: 2215: 2206: 2195: 2126: 2122: 2100: 2091: 2082: 2073: 2062: 2050: 2039: 2027: 2016: 2006: 1993: 1965: 1953: 1944: 1934: 1923: 1866: 1862: 1834: 1825: 1808: 1804: 1794: 1785: 1776: 1765: 1732:. Retrieved 1723: 1709: 1689: 1682: 1670:. Retrieved 1666: 1657: 1647:September 8, 1645:. Retrieved 1641:the original 1636: 1609:. Retrieved 1605: 1596: 1584:. Retrieved 1579: 1570: 1558:. Retrieved 1554: 1545: 1533:. Retrieved 1529: 1527:"Mylan N.V." 1521: 1509:. Retrieved 1505: 1496: 1488:the original 1481: 1472: 1460:. Retrieved 1456:the original 1449: 1440: 1429: 1420: 1408: 1398:December 10, 1396:. Retrieved 1382: 1370: 1279:Tetracycline 1211:human rights 1204: 1189: 1176: 1149: 1145: 1132: 1126: 1110: 1104: 1099: 1095: 1093: 1089: 1065: 1059: 932: 921: 893: 881: 858: 855: 835: 823: 816: 808: 804: 793: 786: 774: 757: 745: 737: 726: 717: 704: 688: 682: 680: 660: 639: 631: 624: 612: 594: 569: 567:facilities. 562: 551: 539: 530: 514: 510: 506: 487: 474: 462: 458: 454:penicillin G 446:Milan Puskar 443: 406: 389:Pennsylvania 366: 310: 299: 276: 239: 238: 204: 170:Headquarters 148:merged with 117:Milan Puskar 67:Company type 29: 5051:Parke-Davis 4734:Trevena Inc 4602:Mentholatum 4410:AbbVie Inc. 4352:SEC filings 3788:. Bloomberg 3626:MarketWatch 3226:October 22, 1530:MarketWatch 1462:January 28, 1346:Parkinson's 1231: [ 1228:DJE Kapital 1072:anaphylaxis 952:Bertek Inc 708:Joe Manchin 700:Joe Manchin 498:triamterene 496:containing 492:that was a 393:Southpointe 333:dermatology 329:respiratory 317:anaphylaxis 306:S&P 500 264:Netherlands 5153:Categories 5111:ViroPharma 5011:Massengill 4739:Ultragenyx 4470:Bioverativ 4213:Pink Sheet 4187:Pink Sheet 3971:. New York 3927:October 8, 3855:October 1, 3473:August 19, 2101:Pink Sheet 2083:Pink Sheet 1734:August 25, 1555:NASDAQ.com 1375:References 1367:Management 1324:Indication 1304:Antibiotic 1290:Cimetidine 1282:Antibiotic 1271:Antibiotic 1260:Indication 1054:See also: 1048:See also: 1028:(Acq 2016) 1022:(Acq 2016) 1014:(Acq 2014) 1012:Famy Care 1008:(Acq 2014) 1000:(Acq 2013) 994:(Acq 2011) 986:(Acq 2010) 980:(Acq 2007) 972:(Acq 2007) 966:(Acq 1998) 960:(Acq 1996) 954:(Acq 1993) 948:(Acq 1991) 942:(Acq 1989) 627:Merck KGaA 602:Carl Icahn 558:selegiline 542:selegiline 516:it to the 385:Canonsburg 381:Pittsburgh 377:Morgantown 341:anesthesia 337:immunology 291:Merck KGaA 240:Mylan N.V. 207:Operations 137:2020-11-16 54:Mylan N.V. 49:Trade name 33:Mylan N.V. 5061:Qualitest 4931:CancerVax 4714:Sheffield 4704:RespireRx 4699:Regeneron 4550:Intercept 4530:Genentech 4520:Eli Lilly 4505:CytoSport 4495:Ceragenix 3996:CNN Money 3646:Money.com 2904:Bloomberg 2739:USA Today 1611:August 8, 1412:Mylan NV 1081:Medtronic 1039:Criticism 819:valsartan 817:In 2018, 576:lorazepam 532:replace. 450:Don Panoz 308:indices. 200:Divisions 160:Successor 121:Don Panoz 4941:CoTherix 4936:Cephalon 4819:Covidien 4809:Allergan 4799:Alkermes 4719:Spectrum 4587:McKesson 4480:Biovista 4460:BioCryst 4245:July 17, 4219:July 17, 4193:July 17, 4167:July 17, 4142:July 17, 4117:July 17, 4092:July 17, 4066:June 25, 4046:21513100 4038:25344344 3833:NBC News 3650:Archived 3314:BioSpace 2602:CBS News 2334:Barron's 2155:28911475 1817:10118987 1717:. Mylan. 1693:. UPNE. 1586:June 11, 1560:June 11, 1535:June 11, 1511:June 11, 1343:Eldepryl 1245:Products 1238:divested 1215:Reprieve 1122:Medicaid 877:Celebrex 765:Allergan 490:diuretic 313:oncology 304:and the 188:Products 152:to form 113:Founders 80:Industry 59:Formerly 5096:Trubion 4946:Covance 4926:Bradley 4875:, 2013) 4873:Ireland 4869:Perrigo 4865:, 2013) 4863:Ireland 4855:, 2012) 4853:Ireland 4845:, 2014) 4843:Ireland 4835:, 2014) 4833:Ireland 4825:, 2007) 4823:Ireland 4815:, 2015) 4813:Ireland 4805:, 2011) 4803:Ireland 4795:, 2013) 4793:Ireland 4789:Actavis 4759:Viatris 4657:Hospira 4647:Ovation 4642:Organon 4637:NovaBay 4622:Moderna 4560:Ethicon 4490:Century 4475:Biovest 4435:Alnylam 4430:Alexion 4420:Advaxis 4398:Current 4287:Questex 4266:Fortune 4062:. Mylan 3975:May 31, 3969:Reuters 3705:Questex 3563:Science 3521:Gizmodo 3427:Questex 3349:May 11, 3339:Reuters 3319:May 11, 3269:Questex 3195:Reuters 3138:WBOY-TV 3117:Questex 3073:Questex 2945:Fortune 2924:Reuters 2884:Reuters 2804:Questex 2760:Gizmodo 2696:Questex 2492:PM Live 2385:May 31, 2262:Fortune 2146:9345453 1902:Page 50 1841:Reuters 1672:July 1, 1357:Allergy 1332:Maxzide 1209:-based 1196:Alabama 898:via an 873:Lipitor 865:Epi-Pen 861:Viatris 789:Meda AB 748:Perrigo 435:History 383:suburb 289:-based 287:Germany 260:Viatris 244:generic 214:Website 164:Viatris 154:Viatris 135: ( 127:Defunct 95: ( 90:Founded 5121:Zonite 5101:Upjohn 5036:Nuvelo 5031:Nereus 5026:Naurex 4951:Cubist 4921:Biolex 4906:Amylin 4773:Former 4754:Vertex 4662:Searle 4652:Pfizer 4465:Biogen 4455:Baxter 4162:CIDRAP 4044: 4036: 3451:Forbes 3289:Forbes 2153: 2143: 1896: 1815: 1697: 1354:EpiPen 1207:London 1085:Sanofi 908:NASDAQ 869:Viagra 671:Advair 663:Pfizer 429:NASDAQ 421:NASDAQ 274:, US. 256:Pfizer 252:Upjohn 226: 221:.mylan 150:Upjohn 71:Public 5116:Wyeth 5106:Verus 5086:Tanox 5066:Rib-X 5041:Ortho 5021:Mylan 4976:Genta 4911:ARIAD 4889:Other 4729:Titan 4694:Quark 4540:Ionis 4510:CytRx 4500:Combe 4440:Amgen 4425:Alcon 4340:Mylan 4042:S2CID 3217:(PDF) 2462:Mylan 1360:2007 1349:1989 1338:1984 1307:2004 1296:1994 1293:Ulcer 1285:1968 1274:1966 1235:] 1105:Times 1100:Times 933:Mylan 890:Stock 652:2010s 586:2000s 548:1990s 471:1980s 403:Stock 279:India 62:Milan 4991:King 4986:ISTA 4966:Epix 4916:Barr 4896:Alza 4247:2018 4221:2018 4195:2018 4169:2018 4144:2018 4119:2018 4094:2018 4068:2018 4034:PMID 4022:2014 3977:2017 3929:2016 3857:2016 3794:2016 3475:2016 3351:2020 3321:2020 3296:2019 3228:2020 2474:2016 2423:ICRM 2387:2022 2151:PMID 1997:FDA 1894:ISBN 1813:PMID 1736:2016 1695:ISBN 1674:2018 1649:2016 1613:2018 1588:2018 1562:2018 1537:2018 1513:2018 1464:2010 1400:2020 1321:Name 1257:Name 1019:Meda 875:and 500:and 448:and 343:and 223:.com 205:see 145:Fate 97:1961 93:1961 5091:TAP 5046:OSI 4240:U.S 4026:doi 4018:BMJ 2405:IHS 2216:FTC 2141:PMC 2131:doi 1871:doi 1219:FDA 904:OTC 844:'s 838:FDA 669:'s 413:OTC 219:www 101:in 5155:: 4996:KV 4305:. 4284:. 4263:. 4238:. 4211:. 4185:. 4160:. 4135:. 4110:. 4084:. 4040:. 4032:. 4020:. 4016:. 4004:^ 3994:. 3967:. 3955:^ 3902:. 3879:. 3865:^ 3830:. 3811:. 3767:. 3746:. 3734:^ 3722:. 3702:. 3669:. 3648:. 3644:. 3623:. 3602:. 3581:. 3560:. 3539:. 3518:. 3497:. 3483:^ 3448:. 3436:^ 3424:. 3391:. 3377:^ 3367:. 3337:. 3312:. 3287:. 3266:. 3245:. 3219:. 3192:. 3135:. 3114:. 3093:. 3070:. 3050:. 3030:. 3010:. 2987:. 2965:. 2942:. 2921:. 2902:. 2881:. 2860:. 2840:. 2801:. 2780:. 2757:. 2736:. 2724:^ 2714:. 2693:. 2674:. 2651:. 2599:. 2578:. 2557:. 2534:. 2500:^ 2490:. 2460:. 2440:. 2421:. 2403:. 2377:. 2359:. 2353:. 2331:. 2308:. 2282:. 2259:. 2247:^ 2235:. 2214:. 2194:. 2180:^ 2163:^ 2149:. 2139:. 2127:23 2125:. 2121:. 2109:^ 2099:. 2081:. 2061:. 2038:. 2015:. 1976:^ 1964:. 1943:. 1922:. 1908:^ 1900:. 1885:^ 1865:. 1861:. 1849:^ 1839:. 1833:. 1807:. 1803:. 1784:. 1764:. 1744:^ 1665:. 1635:. 1621:^ 1604:. 1578:. 1553:. 1504:. 1480:. 1448:. 1428:. 1391:. 1233:de 879:. 871:, 867:, 848:. 431:. 399:. 387:, 371:, 351:, 347:, 339:, 335:, 331:, 327:, 323:, 319:, 315:, 254:, 178:, 105:, 4871:( 4861:( 4851:( 4841:( 4831:( 4821:( 4811:( 4801:( 4791:( 4383:e 4376:t 4369:v 4311:. 4290:. 4269:. 4249:. 4223:. 4197:. 4171:. 4146:. 4121:. 4096:. 4070:. 4048:. 4028:: 3998:. 3979:. 3949:. 3931:. 3908:. 3885:. 3859:. 3836:. 3815:. 3796:. 3773:. 3752:. 3708:. 3675:. 3629:. 3608:. 3585:. 3566:. 3545:. 3524:. 3503:. 3477:. 3454:. 3430:. 3397:. 3353:. 3323:. 3298:. 3272:. 3251:. 3230:. 3141:. 3120:. 3099:. 3016:. 2971:. 2948:. 2927:. 2906:. 2887:. 2846:. 2807:. 2786:. 2763:. 2742:. 2718:. 2699:. 2678:. 2619:. 2605:. 2584:. 2563:. 2540:. 2476:. 2446:. 2425:. 2389:. 2337:. 2314:. 2288:. 2265:. 2241:. 2200:. 2174:. 2157:. 2133:: 2067:. 2044:. 2021:. 1970:. 1947:. 1928:. 1879:. 1873:: 1867:3 1819:. 1809:8 1788:. 1770:. 1738:. 1703:. 1676:. 1651:. 1615:. 1590:. 1564:. 1539:. 1515:. 1466:. 1402:. 824:N 139:) 99:) 20:)

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.